Low Very low-Density Lipoprotein Cholesterol but High Very low-Density Lipoprotein Receptor mRNA Expression in Peripheral White Blood Cells: An Atherogenic Phenotype for Atherosclerosis in a Community-Based Population

被引:7
作者
Zhao, Fan [1 ]
Qi, Yue [1 ]
Liu, Jing [1 ]
Wang, Wei [1 ]
Xie, Wuxiang [1 ]
Sun, Jiayi [1 ]
Liu, Jun [1 ]
Hao, Yongchen [1 ]
Wang, Miao [1 ]
Li, Yan [1 ]
Zhao, Dong [1 ]
机构
[1] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol,Beijing An Zhen Hosp,Minist Educ, Beijing, Peoples R China
来源
EBIOMEDICINE | 2017年 / 25卷
基金
中国国家自然科学基金;
关键词
Very low-density lipoprotein cholesterol; Very low-density lipoprotein receptor; Carotid atherosclerosis; Community-based study; HIGH-AFFINITY RECEPTOR; CAROTID PLAQUE AREA; VLDL RECEPTOR; ULTRASOUND MEASUREMENT; REMNANT CHOLESTEROL; DISEASE; PROGRESSION; LDL; RISK; HDL;
D O I
10.1016/j.ebiom.2017.08.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Very low-density lipoprotein cholesterol (VLDL-C), via binding very low-density lipoprotein receptor (VLDLR), can induce the development of atherosclerosis. Besides monocytes, VLDLR expression is detected in various peripheral white blood cells (WBCs), yet its underlying role remains unclear. We thereby aimed to test the hypothesis that VLDLR in all types of peripheral WBCs may be involved in the association between VLDL-C and atherosclerosis. VLDLR mRNA expression in peripheral WBC and plasma VLDL-C levels were measured in 747 participants from a community-based study. Plaque prevalence and total plaque area (TPA) were used to evaluate the burden of carotid atherosclerosis. VLDL-C was positively associated with atherosclerosis risk, whereas this association was modified by VLDLR mRNA level. In participants with the lowest VLDL-C but the highest VLDLR mRNA expression, the risk for plaque prevalence unexpectedly was the highest. This association was also observed for TPA. Moreover, this association remained unchanged after adjusting for WBC or monocytes. Our findings described an atherogenic phenotype characterized by low VLDL-C but high VLDLR mRNA expression in peripheral WBCs, which suggested that VLDLR in all types of peripheral WBCs may be involved in lipid deposition, and VLDL-C and VLDLR may co-determine the development of atherosclerosis. (C) 2017 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 50 条
  • [31] Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR+/- and LDLR-/-) Yucatan Miniature Pigs
    Burke, Amy C.
    Telford, Dawn E.
    Sutherland, Brian G.
    Edwards, Jane Y.
    Sawyez, Cynthia G.
    Barrett, P. Hugh R.
    Newton, Roger S.
    Pickering, J. Geoffrey
    Huff, Murray W.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (05) : 1178 - 1190
  • [32] Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care
    Bilgic, Selin
    Sniderman, Allan D.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (01) : 49 - 53
  • [33] Low-Density Lipoprotein Cholesterol, Structural Atherosclerosis, and Functional Atherosclerosis in Older Japanese
    Shimizu, Yuji
    Yamanashi, Hirotomo
    Honda, Yukiko
    Nonaka, Fumiaki
    Miyata, Jun
    Kawashiri, Shin-Ya
    Noguchi, Yuko
    Nakamichi, Seiko
    Nagata, Yasuhiro
    Maeda, Takahiro
    NUTRIENTS, 2023, 15 (01)
  • [34] Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis
    Shoji, Tetsuo
    Hatsuda, Sawako
    Tsuchikura, Shoko
    Shinohara, Kayo
    Kimoto, Eiji
    Koyama, Hidenori
    Emoto, Masanori
    Nishizawa, Yoshiki
    ATHEROSCLEROSIS, 2009, 202 (02) : 582 - 588
  • [35] Association between oxidized low-density lipoprotein cholesterol concentration and atherosclerosis
    Savoiu, Germaine
    Cristescu, Carmen
    Serban, Corina
    Dehelean, Cristina
    Dragan, Simona
    Duicu, Oana
    Noveanu, Lavinia
    Borza, Claudia
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2009, 15 (02): : 49 - 54
  • [36] Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype
    Xu, Rui-Xia
    Guo, Yuan-Lin
    Li, Xiao-Lin
    Li, Sha
    Li, Jian-Jun
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2014, 41 (07) : 475 - 481
  • [37] The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation factor VIII
    Ananyeva, Natalya M.
    Makogonenko, Yevgen M.
    Kouiavskaia, Diana V.
    Ruiz, Jose
    Limburg, Vincent
    Meijer, Alexander B.
    Khrenov, Alexey V.
    Shima, Midori
    Strickland, Dudley K.
    Saenko, Evgueni L.
    BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (02) : 166 - 177
  • [38] Effects on Coronary Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol with Statins
    Ferrieres, Jean
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (02) : 109 - 115
  • [39] Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level
    Grabner, Michael
    Winegar, Deborah A.
    Punekar, Rajeshwari S.
    Quimbo, Ralph A.
    Cziraky, Mark J.
    Cromwell, William C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (03) : 404 - 409
  • [40] Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity
    Kim, Oh Yoen
    Lee, Seung-Min
    Chung, Ji Hyung
    Do, Hyun Joo
    Moon, Jiyoung
    Shin, Min-Jeong
    NUTRITION, 2012, 28 (06) : 635 - 639